A peripheral intravenous (IV)
catheter is a commonly used vascular access in medicine. The sizes of
peripheral IV catheters vary according to the application. The diameter of the
catheter is proportional to French gauge and inversely proportional to
Birmingham gauge.
The global Peripheral
Intravenous Catheter Market is estimated to account for US$ 7,535.5 Mn in
terms of value by the end of 2027.
Global Peripheral Intravenous
Catheter Market: Drivers
Increasing development of
advanced peripheral IV catheters equipped with additional safety features to
avoid needlestick injuries is expected to propel growth of the global
peripheral intravenous catheter market. For instance, in July 2018, 3M launched
Tegaderm Antimicrobial I.V. Advanced Securement Dressing and Tegaderm
Antimicrobial Transparent Dressing to enhance its peripheral IV maintenance
solution offerings.
Global Peripheral Intravenous
Catheter Market: Opportunities
Emerging economies are witnessing
high incidence of various disease such as cancer, acute illness, and trauma.
However, the number of healthcare facilities available in these countries is
relatively low. Moreover, the availability of advanced integrated/closed
catheter with safety technology is low. Therefore, key players in the market
can focus on manufacture and distribution of integrated/closed catheter in
these countries.
Global Peripheral Intravenous
Catheter Market: Restraints
Lack of training in use of
peripheral IV catheters is expected to hinder growth of the global peripheral
intravenous catheter market. Proper training for insertion, maintenance, and
removal of catheters may help to avoid the risk factors associated with
complications.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/3208
Key Takeaways:
The Short PIVC segment in the
global peripheral intravenous catheter market was valued at US$ 3,025.4 Mn in
2018 and is expected to reach US$ 4,693.7 Mn by 2027 at a CAGR of 4.9% during
the forecast period. Major factor attributing to the growth of the segment
during the forecast period constitutes of technological advancements in product
development.
The Hospital segment held
dominant position in the global peripheral intravenous catheter market in 2018,
accounting for 62.2% share in terms of value, followed by ambulatory surgical
centers, respectively. The growth of the segment is attributed to increasing
patient population suffering from chronic diseases during the forecast period.
Market Trends
The demand for placing vascular
access specialists in every hospital across the U.S. is increasing in the
recent past. This is owing to increasing number of hospitalizations and focus
on reducing complications including bloodstream infections, which impact patient
outcomes and increase costs.
The market is also witnessing
high adoption of enhanced barrier precautions (EBPs) to prevent the spread of
multidrug-resistant organisms in nursing homes. EBPs can be used in
high-contact resident care activities such as central line, urinary catheter,
feeding tube, tracheostomy/ventilator, and wound care.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/peripheral-intravenous-catheters-market-3208
Regulations
Europe
A medical device only can be
marketed in Europe if it is granted CE Marking. A company can achieve CE
marking for the device from various European regulatory agencies such as the
Medicines and Healthcare products Regulatory Agency (MHRA) and the Health and
Safety Executive (HSE).
The medical device regulation in
Europe is based on a classification of the device into four classes, I, IIa,
IIb, and III. The class I is a low risk
device, class II includes medium risk devices and the class III includes high
risk devices. The peripheral intravenous catheter covers under class IIa.
Peripheral intravenous catheter
convers under medical devices directive 93/42/EEC (MDD). The directive
93/42/EEC includes conformity assessment routes for Class IIa medical devices
such as Annex II for full quality assurance ISO 13485:2003, Annex V for
production quality assurance ISO 13485:2003 (excluding Design) and Annex VI for
product quality assurance ISO 13485:2003 (excluding Design & Manufacture).
The medical devices, which are
submitted to the European government agencies for getting CE marking cannot
refer to the safety and effectiveness of the other medical device that perform
similar function that already got CE marking.
As per the British Standards
Institution (BSI) the manufacturers should registered their devices with
quality management system ISO 13485:2003. According to the quality management
system the devices need to meet specific requirement such as design,
development, manufacturing and distribution.
Global Peripheral Intravenous
Catheter Market: Competitive Landscape
Major players operating in the
global peripheral intravenous catheter market include, Becton, Dickinson and
Company, B. Braun Melsungen AG, Smith Medical, Terumo Corporation, C. R. Bard,
Inc., Tangent Medical, Velano Vascular Inc., and Vygon Group.
Global Peripheral Intravenous Catheter
Market: Key Developments
Key players in the market are focused
on product approval and launch to expand their product portfolio. For instance,
in March 2018, Smiths Medical received the U.S. FDA clearance for its DeltaVen
Closed System Catheter, a product developed by Delta Med SpA.
Key players in the market are
also focused on adopting partnership strategies to expand its product
portfolio. For instance, in March 2019, Delta Med SpA partnered with Levanton,
a producer of infusion devices, to expand its product portfolio.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/3208
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting services,
and competitive analysis through various recommendations related to emerging
market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment